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Severe Progressive Back Pain Causing the Misdiagnoses of Guillain-Barré
Syndrome (Twice)
Abstract
Introduction
Introduction:
Guillain-Barré syndrome (GBS) is a rare autoimmune demyelinating disease. Symptoms vary widely and
commonly include ascending bilateral weakness, pain and hyporeflexia. Approximately 30% will develop
respiratory failure contributing to the high morbidity and mortality. Advancements in diagnostic and
treatment have greatly decreased mortality to now less than 10%. However, GBS is still often
misdiagnosed, thus delaying care.
Case Description
Description:
A 42-year-old female presented with 1 week of back pain that now is affecting her hands and feet. Her
neurological exam was within normal limits. Imaging included brain CT and MRI, chest and abdomen CT,
were all unremarkable along with labs. She was discharged home with pain medication for unspecified
back pain. The next day, the patient presented back to the hospital with progressive weakness and pain
now occurring throughout her body. After additional workup was negative, the physicians were now
considering drug addiction as a diagnosis. She was discharged home and told to follow up with her
primary physician, who urgently referred her to a neurologist. The following morning, the patient saw a
neurologist who recommended a lumbar puncture and nerve conduction study but were not performed
due to insurance complications. She was now unable to walk and told to immediately return back to the
hospital. Upon arrival, her neurological exam deteriorated further, and she was in respiratory distress. A
lumbar puncture showed albuminocytologic dissociation. A nerve conduction study showed multifocal
demyelinating peripheral neuropathy confirming GBS. Intravenous immunoglobin was initiated but despite
several doses, her symptoms continued to worsen. She was intubated and transferred to a tertiary
hospital for plasmapheresis. On Day 14 she had a tracheostomy and a percutaneous endoscopic
gastrostomy tube placed and was discharged to a Long-Term Acute Care Hospital on Day 25.
Discussion
Discussion:
GBS is often misdiagnosed especially when patients present with atypical symptoms, like in this case,
back pain. After the more common etiologies for back pain are ruled out, and with a high index of
suspicion, initiating early neurology consultation and early therapy will help slow progression. Severe
progressive pain, including back pain, is a common presenting symptom and is caused from the
demyelination of peripheral nerves. Multiple medical textbooks and resources emphasize the more typical
symptoms such as progressive ascending neuropathy, yet few highlight the pain severity. Current studies
are underway to help address this matter including increasing physicians’ awareness and comfort with
diagnosing and treating GBS.
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Severe Progressive Back Pain Causing the
Misdiagnoses of Guillain-Barre Syndrome (Twice)
Thien T. Ho*, Suporn Sukpraprut-Braaten, David Martin, Michael Clevenger,
Delaney Kinchen, Stacy Zimmerman, Stephen Wagner
Unity Health, USA

Abstract
Introduction: Guillain Barre syndrome (GBS) is a rare autoimmune demyelinating disease. Symptoms vary widely and
commonly include ascending bilateral weakness, pain and hyporeﬂexia. Approximately 30% will develop respiratory
failure contributing to the high morbidity and mortality. Advancements in diagnostic and treatment have greatly
decreased mortality to now less than 10%. However, GBS is still often misdiagnosed, thus delaying care.
Case description: A 42-year-old female presented with 1 week of back pain that now is affecting her hands and feet. Her
neurological exam was within normal limits. Imaging included brain CT and MRI, chest and abdomen CT, were all
unremarkable along with labs. She was discharged home with pain medication for unspeciﬁed back pain. The next dayr
the patient presented back to the hospital with progressive weakness and pain now occurring throughout her body. After
additional workup was negative, the physicians were now considering drug addiction as a diagnosis. She was discharged home and told to follow up with her primary physician, who urgently referred her to a neurologist. The
following morning, the patient saw a neurologist who recommended a lumbar puncture and nerve conduction study but
were not performed due to insurance complications. She was now unable to walk and told to immediately return back to
the hospital. Upon arrival, her neurological exam deteriorated further, and she was in respiratory distress. A lumbar
puncture showed albuminocytologic dissociation. A nerve conduction study showed multifocal demyelinating peripheral neuropathy conﬁrming GBS. Intravenous immunoglobin was initiated but despite several doses, her symptoms
continued to worsen. She was intubated and transferred to a tertiary hospital for plasmapheresis. On Day 14 she had a
tracheostomy and a percutaneous endoscopic gastrostomy tube placed and was discharged to a Long-Term Acute Care
Hospital on Day 25.
Discussion: GBS is often misdiagnosed especially when patients present with atypical symptoms, like in this case, back
pain. After the more common etiologies for back paiin are ruled out, and with a high index of suspicion, initiating early
neurology consultation and early therapy will help slow progression. Severe progressive pain, including back pain, is a
common presenting symptom and is caused from the demyelination of peripheral nerves. Multiple medical textbooks
and resources emphasize the more typical symptoms such as progressive ascending neuropathy, yet few highlight the
pain severity. Current studies are underway to help address this matter including increasing physicians' awareness and
comfort with diagnosing and treating GBS.
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1. Introduction

G

uillain-Barr
e syndrome (GBS) is a rare autoimmune demyelinating disease, occurring at
approximately 1.72 patients per 100,000 person/year.1
GBS is often preceded by an infection, surgery,

trauma, or vaccination.2 However, the absence of any
previously deﬁned etiology does not necessarily
exclude GBS.3 The most common symptoms include
ascending symmetric bilateral limb weakness and
hyporeﬂexia or areﬂexia.1 Less common symptoms
include severe pain, fever, dyspnea, and paralysis.3
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Up to 30% will develop respiratory failure contributing to the high morbidity and mortality.4,5 The
recent advancements in diagnostics and treatments
have greatly decreased mortality to now less than
10%.6 A common cause of increased mortality is the
failure to appropriately diagnose GBS and initiate
early therapy. Those who are diagnosed late will likely
have a longer hospitalization course and a slower recovery period.
Having an atypical presentation such as non-speciﬁc back pain, normal deep tendon reﬂexes, late
onset weakness, or cranial nerve abnormalities that
mimic stroke, are factors that delay the diagnosis of
GBS.5,7,8 It can take up to 5 visits to the Emergency
Department (ED), with 2 visits being the average,
before GBS is even considered.1 Other etiologies that
can manifest similarly to GBS include peripheral
vascular disease, heavy metal or drug intoxication,
spinal cord ischemia, transverse myelitis, stroke,
polymyositis, or severe metabolic derangements.1
In 2015, Dubey et al. showed in their study that
among the 69 patients that were eventually diagnosed with GBS, the diagnosis was considered in
only 34 (49.3%) of the patients on the initial ED
visit.1 Reasons for this result included patients presenting with atypical symptoms and delayed
consultation with a neurologist. In the same study,
those who were assessed early by a neurologist
during the initial hospitalization, were 71.2% more
likely to be discharged home rather than to a long
term acute care hospital or inpatient rehab.1 Additionally, residual symptoms such as neuropathy or
weakness were more likely to be present on
discharge for those with delayed treatment.1 In this
case study, we describe a patient with GBS that was
diagnosed after her third hospital visit, which
contributed to her complicated clinical course and
her prolonged recovery.

2. Case presentation
ED Visit 1: A 42-year-old female, with essential
hypertension, presented to a community hospital
with a one week history of severe back pain that
radiated to her hands and feet. She denied any
recent illnesses, injuries, medication changes or
vaccinations. On examination, her blood pressure
was elevated at 160/107 mmHg, her other vital signs
were unremarkable. Her cranial nerves, motor
function, and sensation were intact with normal
deep tendon reﬂexes. Imaging included brain
computed tomography (CT) and magnetic resonance imaging (MRI) to exclude stroke, along with
chest and abdominal CT to exclude aortic artery
pathology, were all negative along with her labs.
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GBS was on the differential diagnosis but was
placed much lower as she did not have the typical
manifestations. Without any meningeal signs, the
staff presumed a lumbar puncture would be low
yield. She was discharged home with opiate pain
medication for unspeciﬁed back pain.
ED Visit 2: The next day, the patient presented
back to the hospital with progressive pain and
paresthesia throughout her arms and legs along
with increasing weakness. Aside from mild ataxia
on tandem heel walk, her neurologic exam was,
again, unremarkable. An MRI of her cervical,
thoracic and lumbar spine was performed to evaluate her vertebrae and spinal cord as well as a
repeat CT brain, which were all negative. The physicians were now considering drug addiction as a
possible diagnosis because opiate pain medication
was the only treatment that relieved her discomfort.
She was discharged home and instructed to follow
up with her primary physician. She saw her primary
physician who then referred her urgently to a
neurologist.
ED Visit 3: The following morning, the patient saw a
neurologist at their private ofﬁce, who suspected GBS
and recommended a lumbar puncture and nerve
conduction study. Unfortunately, it would have to be
postponed until approved by insurance. At this point,
she was unable to walk and in a wheelchair. The
neurologist advised her to return back to the hospital
immediately. On arrival, she noticed that her neurologic exam had deteriorated further with areﬂexia
on her lower extremities. She also was in respiratory distress and subsequently admitted to the
Intensive Care Unit. A lumbar puncture was performed showing mild albuminocytologic dissociation: 179 mg/dL (normal range 15e45). A nerve
conduction study followed that showed multifocal
demyelinating peripheral neuropathy consistent
with GBS.
Intravenous immunoglobin (IVIG) was initiated
but despite receiving multiple doses, her symptoms
continued to worsen. She was intubated and transferred to a tertiary hospital for plasmapheresis. She
had a prolonged hospitalization with a tracheostomy and a percutaneous endoscopic gastrostomy
tube placement and was ultimately discharged to a
long term acute care hospital on Day 25.

3. Discussion
An important aspect of this clinical case was the
patient's initial chief complaint of severe progressive
pain that started in her back. This atypical presentation of GBS misled the initial physicians. However,
progressive severe pain, including back pain, is a
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common presenting symptom that is seen in more
than 50% of cases and is caused from the autoimmune
demyelination of the peripheral nerves.6,8 Furthermore, one third of cases will have pain preceding limb
weakness and neuropathy.7 The reason why this is
problematic is because many medical textbooks,
journals, and medical resources place the most
emphasis on the more typical symptoms such as
progressive symmetric bilateral neuropathy, areﬂexia, cranial nerve abnormalities, and respiratory
dysfunction. Yet, there is hardly any emphasis on the
pain severity with GBS, which delays the diagnosis
during its early phases.7
Another key factor that delayed this patient's
diagnosis was that the community hospital did not
have inpatient neurology services readily accessible. A neurologist may have provided additional
insight into the atypical symptoms of GBS in this
case and recommend further testing (i.e. lumbar
puncture) and starting treatment early. The challenging part for physicians is deciding which
symptoms warrant neurology consult and further
workup, especially during the initial stages. Current studies are underway to increase physicians'
awareness and comfort with diagnosing and treating GBS.1
The neurologist that the patient saw had advised
the hospital to perform the lumbar puncture and the
nerve conduction study, which helped diagnose and
conﬁrm GBS. It is likely her symptoms had been
ongoing for longer than a week prior to testing,
which increases the sensitivity of these tests.8
However, if the tests were performed within a week
of the patient's symptoms or performed in cases of
mild GBS disease, the results might not have been
diagnostic. Repeating diagnostic studies at a later
time (approximately 2e3 weeks later) would be
helpful to conﬁrm the diagnosis.8 Nonetheless, GBS
is a clinical diagnosis and treatment should be
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started promptly with IVIG or plasmapheresis,
especially when symptoms rapidly progress.8
Treatment should not be withheld while waiting for
conﬁrmation testing.
In conclusion, this case report highlights the
challenges physicians have in the diagnosis of GBS
in patients presenting with atypical symptoms such
as back pain. Although medical literature does not
emphasize pain being associated with GBS as much
as other common symptoms, pain is still frequently
seen. GBS is rare and if there is a high index of
suspicion, neurology should be consulted promptly
to determine if further testing, including lumbar
puncture, is warranted after the more common etiologies are excluded.
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